Search results
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade via AOL· 2 days ago"Scientifically, there are two likely mechanisms: direct viral invasion and/or indirect...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoTwo other RSV vaccines, Arexvy from GlaxoSmithKline (GSK...to use mRNA, the same vaccine technology...
We May Be One Step Closer To Male Birth Control. We Asked Guys If They'd Use It
HuffPost Life via Yahoo News· 9 hours agoWould you still be willing to take it? No question. Sign me up. I would certainly monitor the side ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 21 hours agoMore choice and tailored vaccine administration According to GlobalData’s pipeline drugs database,...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoThat pre-filled syringe is just so easy for pharmacists to utilize." The RSV vaccine could be a big...
Fauci defends his work on COVID-19, says he has an ‘open mind’ on its origins
North Dakota Monitor via Yahoo News· 4 days agoWASHINGTON — Dr. Anthony Fauci defended his decision-making during the COVID-19 pandemic on Monday,...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 2 days agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
‘I took an oath to do no harm’: The two doctors wrestling over Fauci’s legacy
Washington Post· 5 days agoFour years later, the Republican congressman is still thinking about China’s potential links to ...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 7 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.